Soleno Therapeutics Uk Ltd
09563670
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 02/09/2025
Due 16/09/2026
Industry
Officers
director · Since 27/04/2015
CHIEF EXECUTIVE OFFICER
AMERICAN · UNITED STATES · Age 58
Persons with Significant Control
Soleno Therapeutics Inc
Suite 400, 100 Marine Parkway, Redwood City, CA 94065
Reg: Slno · Usa · Us Quoted Company
Notified 31/07/2017
CompanyRankvs 1420+ SIC 72110 peers53
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£152
Balance sheet strength
Cash
£193k
Cash in the bank
Net Current Assets
£324k
Working capital
Current Assets
£1.3M
Current Liabilities
£1.0M
Debtors
£1.1M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 1.32 | — |
| 2022 | 1.13 | — |
| 2019 | 2.65 | -£52 |
| 2018 | 2.68 | — |
Derived from filed accounts. Not audited figures.